We have located links that may give you full text access.
Journal Article
Review
Fibroepithelioma of Pinkus Revisited.
Dermatology and Therapy 2016 September
BACKGROUND: Fibroepithelioma of Pinkus (FeP) is considered a variant of basal cell carcinoma (BCC); however, in the past 20 years, some researchers have argued for its classification as a trichoblastoma. Recently, use of a new immunostaining marker and further dermoscopic characterization of FeP have advanced the debate about its proper classification.
PURPOSE: A review of the evidence for and against classification of FeP as BCC or trichoblastoma is presented.
METHODS: Using PubMed, the term FeP was searched and relevant citations were assessed. Additional relevant articles were identified from references of key papers.
RESULTS: FeP shares characteristics of both trichoblastoma and BCC.
CONCLUSION: Derived from the same cell type, BCC and trichoblastoma may be best considered as representing opposite ends of a spectrum of differentiation, with FeP deserving an intermediate classification.
PURPOSE: A review of the evidence for and against classification of FeP as BCC or trichoblastoma is presented.
METHODS: Using PubMed, the term FeP was searched and relevant citations were assessed. Additional relevant articles were identified from references of key papers.
RESULTS: FeP shares characteristics of both trichoblastoma and BCC.
CONCLUSION: Derived from the same cell type, BCC and trichoblastoma may be best considered as representing opposite ends of a spectrum of differentiation, with FeP deserving an intermediate classification.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app